Lindsey Trickett
Investor Relations Contact bij F-STAR THERAPEUTICS, INC.
Oorsprong van het eerstegraads netwerk van Lindsey Trickett
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 16 | |
Subsidiary | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Lindsey Trickett via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Compliance Officer Director of Finance/CFO | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Baker Bros. Advisors LP
Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
ZS PHARMA INC | Pharmaceuticals: Major | Director/Board Member | |
PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Michigan State University | College/University | Undergraduate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Pennsylvania | College/University | Doctorate Degree | |
Imperial College London | College/University | Graduate Degree | |
Drexel University | College/University | Masters Business Admin | |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
McGill University | College/University | Doctorate Degree | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree | |
University Of Dundee | College/University | Doctorate Degree | |
Ursinus College | College/University | Undergraduate Degree | |
University of Brighton | College/University | Undergraduate Degree | |
University of Hertfordshire | College/University | Undergraduate Degree | |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Director/Board Member | |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MERUS N.V. | Biotechnology | Director/Board Member | |
Astra Pharmaceuticals Ltd.
Astra Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Astra Pharmaceuticals Ltd. manufactures & wholesales pharmaceutical products. The company was established in 1908 and is headquartered in London, GB | Pharmaceuticals: Major | Corporate Officer/Principal | |
ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member | |
F-star Alpha Ltd.
F-star Alpha Ltd. BiotechnologyHealth Technology F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer | |
IMAGO BIOSCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Biotechnology | Director/Board Member | |
NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Human Resources Officer | |
Ellipses Pharma Ltd.
Ellipses Pharma Ltd. Pharmaceuticals: MajorHealth Technology Ellipses Pharma Ltd. engages in the development of cancer medicines and treatment drugs. The company was founded by Christopher Evans and Rajan Jethwa in April 14, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
89BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Alumis, Inc.
Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Corporate Officer/Principal | |
OMEGA ALPHA SPAC | Financial Conglomerates | Director/Board Member | |
ACELYRIN, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Human Resources Officer |
Statistieken
Internationaal
Verenigde Staten | 35 |
Verenigd Koninkrijk | 10 |
Canada | 2 |
Nederland | 2 |
Italië | 2 |
Sectoraal
Health Technology | 33 |
Consumer Services | 13 |
Finance | 4 |
Commercial Services | 3 |
Operationeel
Director/Board Member | 72 |
Independent Dir/Board Member | 44 |
Corporate Officer/Principal | 38 |
Undergraduate Degree | 15 |
Chief Tech/Sci/R&D Officer | 15 |
Sterkste connecties
Insiders | |
---|---|
David Bonita | 27 |
Paul Friedman | 21 |
Julian Baker | 20 |
Mardi Dier | 18 |
Martin Babler | 13 |
James Sandy | 9 |
Victor Sandor | 9 |
Bryant Lim | 9 |
Neil Brewis | 8 |
Jane Huang | 8 |
Andrew Combs | 7 |
Wan-Jen Hong | 5 |
Michele Porreca | 5 |
Krishna Vaddi | 5 |
Aimee Crombie | 5 |
- Beurs
- Insiders
- Lindsey Trickett
- Bedrijfsconnecties